New Report Analyzes the Potential of Therapeutic Monoclonal Antibodies in India PR.com (press release) Globally there are only 2 approved biosimilar monoclonal antibodies with Reditux (Rituximab) (developed and manufactured by Dr. Ready's, an Indian generic manufacturer) being one of them. As a result, India and its biosimilar manufacturers can be ... Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market ... |
